Delivery Order SPE2DB25D3017-SPE2DB25FVKRY
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens with a ceiling value of $4,398.30. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a $1,534.20 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on September 22, 2025, with a completion date of September 23, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a $1,200.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin pens, with an ultimate completion date of September 4, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $4,038.26 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on June 13, 2025, with an ultimate completion date of June 16, 2025. This firm fixed-price, competitively awarded contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,505.59 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order valued at $2,473.93 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens on August 4, 2025, with completion targeted for August 5, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026. The...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $5,400.29 on June 2, 2025, for the supply of Lantus SoloStar 100 Unit/ml 3ml insulin pens. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $4,253.11 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens. The contract was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, under a firm fixed-price arrangement with no set-aside designation. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $2,045.86 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on September 24, 2025, with an ultimate completion date of September 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger federal contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,433.85 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 unit/mL insulin pens (3mL) on October 16, 2025, with an ultimate completion date of October 17, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKRYDelivery Order
The Defense Logistics Agency awarded a $1,350.99 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens, with an ultimate completion date of September 18, 2025. This firm fixed-price, non-set-aside contract was awarded competitively on September 17, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement needs across the Department of Defense and allied healthcare systems. The company maintains an extensive portfolio of federal contract awards with DLA covering a broad range of therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. This particular delivery order for Lantus insulin reflects AmerisourceBergen's ongoing role in providing essential diabetes management medications to support the healthcare needs of the military and veteran populations served through the Defense Health Agency and related federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/17/25 |